The Commission, through its Health Emergency Response and Preparedness Authority (HERA) and the European Investment Bank, has today signed a €20 million agreement with the French biopharmaceutical company Fabentech. The agreement will allow the company to develop and deploy its broad-spectrum medicines to combat biological threats to public health.
The threat analysis conducted by HERA demonstrated the importance of developing Fabentech’s Technology Platform, which is based on the production of broad-spectrum polyclonal antibody fragments that recognise and neutralise pathogens and toxins in the human body. Through its integrated R&D and bioproduction capabilities, Fabentech aims to rapidly develop and produce new immunotherapies to increase the effectiveness of the response to public health emergencies.
Today’s agreement is the first of its kind under HERA Invest. Further investments with other European companies are in the pipeline. They will drive innovation to respond to major health threats, such as pathogens with high pandemic potential, chemical, biological, radiological and nuclear (CBRN) threats and antibiotic resistance. HERA Invest, a HERA flagship initiative, is a €100 million complement to the InvestEU programme, funded by the “EUproHealth programme”, which ultimately aims to protect citizens from health threats.
In 2022, HERA, together with Member States, identified three major health threats for which preparedness is essential. To address potential gaps in the availability and accessibility of medical countermeasures, HERA supports the development, production capacity and expansion of manufacturing, procurement and potential storage of medicines, diagnostic equipment, medical devices and personal protective equipment, as well as other medical countermeasures. In this respect, HERA collaborated with the European Investment Bank (EIB) to establish HERA Invest.
More information: European Commission
Publicaciones relacionadas:
Commission proposes a progressive roll-out of the new In Vitro Diagnostic Medical Devices Regulation
European Commission and United States sign health agreement
Commission approves second Spanish “umbrella” scheme to support economy in coronavirus outbreak
Spring 2020 Economic Forecast: A deep and uneven recession, an uncertain recovery
European Commission unveils EU vaccines strategy
Leave a Reply